Member Info for MIKODX

Correction.

gkb47 - If you click on "Show additional CPV codes for this notice" it tells you it's swab tests, so not ODX.

ODX has another strong week, must say I'm surprised. I thought news of the vaccine arriving would have a negative affect on the SP, but that's not been the case. Omega has been one of the stronger stocks out of most of the Pharma stocks so far. Can they hold above 50 again next week with no news? It will be interesting to see.

OptimistPr1me - more than likely not, but one thing I will say is, someone that creates fake accounts and are involved in stock like YGEN, I3E, and ICON, need to have their heads checked.

Good day.

I sold out last week and done ok with this stock. A good stock for the long term but how far it will go is anyone's guess. I might be back I might not, we'll see how it goes.

Careful of the derampers but be even more careful of the rampers, they're bad for your sanity and even worse for your pocket. But lastly and most importantly DYOR.

GL

Does anyone know if there is a minimum Share price requirement to trade on the LSE, I know it's $1 on the Nasdaq?

I must of missed that part, my bad.

Someone asked the same question about delisting from the Nasdaq which left me and the presenter totally scratching our heads. Why would they delist from the Nasdaq? I think you mean delist from the AIM onto the main LSE, which Rockz just kindly cleared up.

DYOR

Lot's of talk about the Covid Inhaler. Trials are ongoing in Brazil with enough cash in the bank to move onto phase 2 and phase 3 trials if successful. Trials will complete at end of December with results in early Q1 2021.

Phase 2a studies with oncology has also been successful, now entering Phase 2b with again enough cash in the bank to cover.

Stemprinter has already showed proof of concept in 3.3200 patients. Now looking to commercialize.

Shocking that not one question was asked about delisting from the AIM and onto the main LSE, which is supposed to be happening this Q4.

Apart from that, it was a very forward looking presentation with lots of successes with all treatments.

Hasn't your carer arrived yet?

Must be one of those rampers.

There's a few interesting comments on here, but also a lot of childish squabbling going on. I can't believe these people who are squabbling are serious investors.

You have people accusing others of deramping , everyone is entitled to their opinion just ignore them. Anyway I find it's normally a ramper that calls out derampers. Rampers hate to hear anything negative about the stock they hold, even if the negative comment is true. It's the rampers you need to watch, they say anything to get you to part with your hard earned money knowing full well the stock is heading downhill. I'd take a honest deramper over a lying ramper everyday of the week.

Anyway back to the topic. AFC looking very strong lately and I'm loving it. Question is, how long will it last? We shall see.

13% rise, ODX looking strong.

This time last year ODX were trading at 10p, the high for that year was 14p. When the consortium was formed back in April, within two weeks the SP had jumped to 60. The reason it jumped to 60 was because of the sheer number of investors that clambered on board, not actual Sales.

What that tells me is that the MCAP was determined not only by company performance but mainly by Trade volumes. Good news or actual Sales need to come soon for ODX and I hope they get it, they've come a long way from where they were.

These are exciting times for AFC.
Hopefully the 30's will now be our new support level.

Meanwhile companies like Abbot and Inova have gatecrashed the party and snapped up the Antigen Govt contracts from right under our noses.

Don't mean to deramp but this is what is happening. Mologic still have time to get in but wish they'd get a move on.

Shares are getting snapped up at this ridiculous price.

First it was we would see an uptick when drilling starts, now we know drilling has started, it's now we'll see an uptick after drilling results. What a joke, which one is it.

Private placings don't sit well with me. Shareholders should have been informed that a placing was taking place. Excess share dilution is not a good look, it's no wonder the SP is falling. But I do expect a turnaround very soon as we know this stock is capable of jumping 50% or more in a single day, and with the second rig about to start drilling, this is highly possible.

Gla

I would say more a strong long term outlook.

Nothing for the short term until more news imho.

Just watched it.

Financially secure which they should be after the Fundraise.

Food Tolerance up 13% on last year.

Antigen tests may not be ready until early next year.

Antibody tests will be ramped up alongside Vaccines (he hopes).

No clarification on the 250,000 or 300,000 antibody tests per week, so we can safely assume that's not going to happen.

Production scale up on track almost complete.

End

Good morning, just joined the party.

GLAH

"Personally, I cannot understand why we are at this price considering all the people that were buying at £1, 90p, 80p 70p etc. all thought this was great value then, since that time news has actually got better and yet some even wonder if they should buy when the opportunity is given to them at 50p".

The reason it has dropped to 50 is because of the BMJ report. Investors were hoping to get more clarification on the tests, and definitive numbers currently and for the foreseeable future, being produced. Previously we were told specific numbers of tests that would be produced per week. These targets have obviously not been met, and we are now being told production is ongoing without any definitive amounts. Why the secrecy? Which is why it will stay under 50 for now with the odd tree shake here and there.

Hopefully we will get better clarification in the Presentation.